Abstract
Introduction Robust empirical data on suicide awareness are needed, to better plan and evaluate suicide prevention interventions. However, there is a lack of validated measures of suicide awareness. This is especially true for perceived suicide awareness, which focuses on perceived knowledge about suicide, willingness, and confidence to talk about suicide and get help. This study aimed to validate a measure of perceived suicide awareness.
Methods We re-used data from a suicide prevention trial conducted in Swiss secondary schools (n=366). Baseline and one-month follow-up data were used to validate the scale. The main measure was an initial 14-item perceived suicide awareness scale (PSAS). Perceived knowledge of help-seeking resources, suicide-related knowledge, and support networks were used to assess convergent validity.
Results A nine-item version, the PSAS-9, showed satisfactory psychometric properties, including high internal consistency (α=.78), acceptable test-retest (r=.68), and a one-factor structure explaining 95% of the variance. The convergent validity was acceptable (.19≤r≤.40). The PSAS-9 was not correlated with suicide-related knowledge (r=.02).
Conclusion This study was an important step towards validating a perceived suicide awareness scale, distinct from suicide-related knowledge, to be used in future studies focused on suicide prevention, and, more generally, studies interested in measuring suicide awareness.
- Adolescents
- Mental Health
- Primary prevention
- Psychometrics
- Suicide
- Suicide awareness
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The work was supported by Promotion Sante Suisse.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study protocol was submitted to the cantonal ethic committee (Geneva, no. 2019-00295). It was considered as falling outside the scope of the Swiss legislation (Federal Act on Research involving Human Beings).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Data availability statement: Anonymized data are available on reasonable request to the corresponding author.
Funding statement: The work was supported by Promotion Santé Suisse.
Conflict of interest disclosure: The authors report no conflict of interest.
Ethics approval statement: The study protocol was submitted to the cantonal ethic committee (Geneva, no. 2019-00295). It was considered as falling outside the scope of the Swiss legislation (Federal Act on Research involving Human Beings).
Patient consent statement: Participants signed a written informed consent.
Permission to reproduce material from other sources: Not applicable.
Clinical trial registration: Not applicable.
neslie.nsingi{at}umanitoba.ca
katia.iglesias{at}hefr.ch
marlene.sapin{at}fors.unil.ch
Data Availability
Anonymized data are available on reasonable request to the corresponding author.
